Investing.com-- AbbVie Inc (NYSE:ABBV) said on Monday evening it reached a deal with the Donald Trump administration to cut the prices of its treatments in Medicaid, with the drugmaker also pledging a ...

Investing.com-- Bitcoin edged lower on Monday after initially rising in early Asian trade, remaining range-bound from last week as risk appetite stayed on edge amid heightened ten ...

Investing.com-- Lynas Rare Earths Ltd (ASX:LYC) said on Tuesday CEO and Managing Director Amanda Lacaze will retire after 12 years in the role, although she will stay with the company until the end of ...

"Effective immediately, any Country doing business with the Islamic Republic of Iran will pay a Tariff of 25% on any and all business being done with the United States of America. This Order is final ...

Investing.com -- The U.S. Food and Drug Administration (FDA) approved Zycubo (copper histidinate) injection on Monday as the ...

The home goods retailer has co-developed Google’s Universal Commerce Protocol (UCP), an open standard that aims to enable ...

Warren’s statement comes as shares of lenders and credit card firms have faced pressure following Trump’s call for a one-year ...

Investing.com -- GeneDx Holdings Corp (NASDAQ:WGS) stock fell 14% Monday after the genomic testing company’s 2026 guidance failed to impress investors despite reporting solid preliminary results for ...

Investing.com -- The Federal Communications Commission revised a rule on Monday that required Verizon Communications (NYSE:VZ) to unlock its handsets 60 days after activation.

Investing.com -- BioAge Labs, Inc. (NASDAQ:BIOA) stock surged 21% Monday after the clinical-stage biopharmaceutical company announced additional positive interim data from its Phase 1 trial of BGE-102 ...

The Euro (EUR) traded with mixed momentum on Monday amid renewed geopolitical unease after comments from US President Donald ...

Investing.com -- Barclays said software stocks could finally catch a break in 2026, given a supportive setup after a year of underperformance driven by valuation pressure and skepticism around AI.